Clarient has received a patent for its technology that detects rare cancer cells in patients' blood and blood marrow.
Published in Brief:
|Senior Director, Biostatistics||
|Associate - Food and Drug||
Keller and Heckman LLP
|Senior Paralegal - Research & Development, and Medical||